Back to search

Democritus University of Thrace (DUTH)

Μελέτη μοριακών δεικτών στον καρκίνο των ωοθηκών

Abstract

dc:description

Ovarian cancer is one of the most common types of cancer and the leading cause of death due to gynecological malignancies. It is well established that dense CD8+ T-lymphocyte infiltration within the ovarian tumor masses correlates with favorable prognosis and improved patient survival. Still, the genes and the underlying molecular mechanisms that govern the recruitment and infiltration of T- lymphocytes in ovarian cancer remain quite vague. The aim of the present thesis was to identify genes involved in T-lymphocyte infiltration and to investigate their prognostic value and their role in the recruitment of lymphocytes in early stage ovarian cancer. In an attempt to pinpoint genes involved in CD8+ T-lymphocyte recruitment at the early stages of the disease, we focused in stage I and II ovarian tumors. To this end, a fluorescent Differential Display approach was utilized and 128 genes over-expressed in ovarian tumors with high numbers of CD8+ T-lymphocytes were identified. The expression of a significant number of genes was further evaluated with qPCR in a cohort of 38 early-stage ovarian cancer patients and a significant positive correlation of the mRNA levels of CXCL9, SMARCE1, MEIS1, GPC6, TMEM132D and JAG1 with the expression levels of CD8A, a marker of CD8+ T-lymphocyte infiltration, was documented. Importantly, forced over-expression of the chromatin remodeler SMARCE1 in SKOV3 ovarian cancer cells after transfection enhanced the expression of the chemokines IL8, RANTES and MIP1B and triggered the chemotaxis of CD8+ T-lymphocytes in vitro. Similarly, over-expression of the transcription factor MEIS1 in SKOV3 cells resulted in secretion of the chemokines IL8, GROα, RANTES, MIP1B, PARC and NAP2 and enhanced chemotaxis of CD8+ T-lymphocytes. Furthermore, MEIS1 was able to bind to the above chemokine promoters both in vitro and in vivo as found by Electrophoretic Mobility Shift Assays and Chromatin Immunoprecipitation. Finally, in order to evaluate the prognostic value of the genes identified with the fluorescent Differential Display, a retrospective clinical analysis of the survival of the early-stage ovarian cancer patients was performed. The expression of GPC6 and TMEM132D correlated with the overall survival of the patients and thus the two genes could serve as prognostic markers in early stage ovarian cancer. To sum up, in the present thesis several genes that could be used as markers of CD8+ T-lymphocyte infiltration and with prognostic value in early stage ovarian cancer were identified. Furthermore, two novel mechanisms regulating CD8+ T-lymphocyte recruitment at the tumor masses were demonstrated.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Karapetsas, Athanasios
  • Καραπέτσας, Αθανάσιος

Subjects

dc:subject × 38

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36871

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Karapetsas, Athanasios; Καραπέτσας, Αθανάσιος. Μελέτη μοριακών δεικτών στον καρκίνο των ωοθηκών. Democritus University of Thrace (DUTH), 2014. http://hdl.handle.net/10442/hedi/36871